SERPINB5 and neoplasm: In this study, we therefore analyzed immunohistochemical stainings in BXs and RXs of four established tumor suppressors (P53, P16, PTEN and maspin) in viable patient-derived tissue before and after neoadjuvant chemotherapy in order to better understand their changes during chemotherapy, and to find out if this change is related to chemotherapy response or survival.